chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report has been received from a physician referring to a 20 years old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were unknown. On 20-JUN-2018, the patient was vaccinated with the first dose of GARDASIL 9 (route, batch/lot# and expiration date unknown) for an unknown indication. On 15-AUG-2018, the patient was vaccinated with the second dose of GARDASIL 9 (route, batch/lot# and expiration date unknown). On 27-AUG-2018, the patient was inadvertently vaccinated with the third dose of GARDASIL 9 (route, batch/lot# and expiration date unknown) (inappropriate schedule of vaccine administration). No adverse effects reported.
Have Bell's Palsy.  Took prednisone 60 mg for 7 days and 3 grams of valacyclovir for 7 days.  Taking Tylenol (325 mg) every 4-6 hours
Information has been received from a 41 year old female patient who in "1999" was vaccinated with her first dose of MMR II (lot # not provided).  After getting the vaccine the patient experienced allergic reaction like throat swelling.  The patient had sought unspecified medical attention on an unspecified date.  The patient's allergic reaction like throat swelling improved.  The outcome of the patient's allergic reaction like throat swelling was not reported.  No further information is available.
Information has been received from a mother concerning her 2-month-old son who was vaccinated with a dose of Rotateq vaccine (human-bovine). The patient's mother reported that her son subsequently developed blood in the stool. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Upon internal review, blood in the stool was determined to be an other important medical event. No further information is available.
Later that day I had joint aches and muscle pain. Overnight I had chills and sweats, headache, and earache
Right shoulder locks up; BNT162B2 was administered before 19 days of previous dose; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the right arm on 22Feb2021 at 14:00 (at the age of 69-years-old) as a single dose of COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the left arm on 16Feb2021 (at the age of 69-years-old) as a single dose of COVID-19 immunisation. On 23Feb2021 at 14:30, the patient's right shoulder locked up. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event right shoulder locks up was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
DEATH; HEART ATTACK; This spontaneous report received from a patient via social media via a company representative concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination (Dose number in series 1). The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, "the patient experienced heart attack and the patient died". It was unspecified if an autopsy was performed. Cause of death was unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died on an unspecified date, and the outcome of heart attack was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0: 20211261673 -COVID-19 VACCINE AD26.COV2.S-Death, Heart attack. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Nurse squeezed arm while giving the injection, I think maybe some of it may have been subcutaneous. Within 2-3 hours I had a huge Hive that covered the injection site and well under it and it itches. Today (9/22/2018) my arm is hot and there is a clear red area, the size of the welt yesterday and it is hot. Been taking Benadryl around the clock to help with the inflammation and itchiness.
Chills, severe headache, muscle pain, injection location pain, tight chest, fever, rash/bumps on the arm of the injection site, tiredness, drowsiness, dizziness and difficulty breathing.  Symptoms lasted approximately 24-36 hours
Left supraclavicular lymphadenopathy; This is a spontaneous report received from a contactable Other HCP (Patient). A 32-years-old (Non pregnant) female patient received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EL9266), via an unspecified route of administration on Left arm on 21Feb2021 09:45 (at age of 32-years-old) as single dose for COVID-19 immunization. The patient medical history was not reported and no Allergies to medications, food, or other products. The historical vaccine included first dose of BNT162B2 received on 25Jan2021 09:30 for COVID-19 immunization. The patients concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Prior to vaccination, patient diagnosed with COVID-19. On 21Feb2021 13:00, patient experienced left supraclavicular lymphadenopathy. Since the vaccination, patient not tested for COVID-19. The outcome of the event was not recovered.
Two days after receiving the vaccine I began to feel physical sick. I had a fever chills my glands under my ears became swollen the size of Jack balls and extremely painful. I developed horrible pains in my stomach with diarrhea. I had a headache with brain fog and confusion. The most frightening was an inability to stay awake. I wasn't fatigue...it was the feeling you'd get from a post op drug or opiate. I couldn't stay woke. My joints aches and I had no appetite. I felt like I was very very sick. I believe if I took the second shot it would kill me. I called my Dr of course and had a virtual visit. He said he thought the side effects would pass ...to take Tylenol for pain...etc etc. These side effect lasted three plus weeks. I feel that I am still not 100% myself.  After the third week I physically saw my Dr. Informed him that I was still having problems. And could only treat the symptoms. Im sorry I took the vax and wish I could turn back time.
difficulty in raising or extending the injected arm; chest soreness on side of injection; shoulder pain; right side of her upper body became sore; arm pain/ soreness in the injected arm (Right); This non-serious case was reported by a consumer via call center representative and described the occurrence of injected limb mobility decreased in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (On an unknown date, the patient received 1st dose and experienced injection site pain, refer case - US2023AMR106739).   On 31-JUL-2023, the patient received the 2nd dose of Shingrix (right arm). On 31-JUL-2023, less than a day after receiving Shingrix, the patient experienced pain in arm (Verbatim: arm pain/ soreness in the injected arm (Right)) and general body pain (Verbatim: right side of her upper body became sore). On an unknown date, the patient experienced injected limb mobility decreased (Verbatim: difficulty in raising or extending the injected arm), chest pain (Verbatim: chest soreness on side of injection) and shoulder pain (Verbatim: shoulder pain). The outcome of the injected limb mobility decreased was not resolved and the outcome of the chest pain, pain in arm, shoulder pain and general body pain were unknown.   It was unknown if the reporter considered the injected limb mobility decreased, chest pain, pain in arm, shoulder pain and general body pain to be related to Shingrix.     It was unknown if the company considered the injected limb mobility decreased, chest pain, pain in arm, shoulder pain and general body pain to be related to Shingrix.   Linked case(s) involving the same patient:  US2023AMR106739   Additional Information: GSK Receipt Date: 04-AUG-2023 The patient self-reported this case. The patient reported shoulder and arm pain and chest soreness on side of injection. The patient received the second dose of Shingrix and later that evening she experienced soreness in the injected arm.  The patient stated that the soreness became worse the next day as the whole right side of her upper body became sore.  The patient had difficulty in raising or extending the injected arm. The reporter consented to follow up.; Sender's Comments:  US-GSK-US2023AMR106739:Same reporter, different dose
severe frontal, bilateral headache lasting for a days (suspect migraine but patient has not had migraine before)
Hives like bug bites and mosquito bites all over different parts of her body; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. Other Case identifier(s): US-PFIZER INC-202200175739 (PFIZER).  A female patient received bnt162b2 (BNT162B2), administration date 26Jan2022 16:30 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: URTICARIA (non-serious), outcome "unknown", described as "Hives like bug bites and mosquito bites all over different parts of her body".  Additional Information: Covid-19 Vaccine was a Pfizer product. Reporter stated that his girlfriend got a Pfizer shot on Wednesday at 4:30 PM and she was visited with him and she was got hives like bug bites and mosquito bites all over different parts of her body. Trying to see if this was side effects or was part of side effects or some other thing going on.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Reddened raised area noted around injection site.  Verbalizes that it is itching at site.   Employee was informed that for continued issue to visit PCP.  At this time has not seen PCP.
PT states being "in and out of breath" earlier today with left neck soreness with a "hard lumps" (x2) to left shoulder/lower neck.  PT is alert and oriented, ambulates with a steady gait, states getting the COVID (moderna) on 3June on the right deltoid. small raised areas noted to left lower neck and upper shoulder (small diameter with round edges, no discharge). Patient states localized painful. Denies difficulty breathing.
EXPIRED VACCINE ADMINISTERED; This spontaneous report received from a pharmacist concerned a 32 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: patient was not having any illness at the time of vaccination. patient was not having any history of similar events. patient was not having adverse event after any previous vaccination(s). patient was not having any food, drug, or vaccine allergy. patient was not having any pre-existing acute illness 30 days prior to vaccination. patient was not having the history of hospitalization in last 30 days. patient was not having any family history of any disease (relevant to vaccination) or allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 211A21A, expiry: 14-DEC-2021) dose was not reported, administered on 15-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On 15-DEC-2021, the patient experienced expired vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine administered was not reported. This report was non-serious. This case, from the same reporter is linked to 20220210382.
Reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Reaction). At the time of the report, VACCINATION COMPLICATION (Reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
1st day p/shot continuous crying x 2 hrs @ very high pitch afebrile; 2nd day still had off & on very high pitched cry was taken to hosp; mom told was rxn from shot; last 3 days-hardly slept;
pediatric patient was accidentally given an adult dose of Havrix; pediatric patient was accidentally given an adult dose of Havrix; This case was reported by a nurse via call center representative and described the occurrence of accidental overdose in a 24-month-old patient who received HAV (Havrix adult) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 2nd September 2021, the patient received Havrix adult and Havrix Pre-Filled Syringe Device. On 2nd September 2021, unknown after receiving Havrix adult and Havrix Pre-Filled Syringe Device, the patient experienced accidental overdose and adult product administered to child. On an unknown date, the outcome of the accidental overdose and adult product administered to child were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided are as follows: Nurse stated that a pediatric patient was accidentally given an adult dose of Havrix about 30 minutes ago, which led to accidental overdose and adult product administered to child.  This vaccine was the patient's final dose in the Hepatitis A series. Lot number was not available at the time of call. The reporter consented to follow-up. The case was linked with case US2020198077 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020198077:Same reporter
Started with behavior issues, and then over the next few days and months continued as arm movements, tics, OCD, whole body movements of arms and legs at night...
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with a dose of VAQTA (lot number, expiration date, dose, route were not reported) and a dose of LIQUID PEDVAXHIB (lot number, expiration date, dose, route were not reported) that were improperly stored. No adverse effects were reported. Additional information has been requested.
Injection site was red, swollen/raised, itchy, painfull thru to today 01/08/2021. Bodily reactions are achy, fatigue, drowsy, headaches, mild temp up to 100.0 (01/07/2021). As of 01/04/2021, other than temperature differences, my other bodily symptoms we minimum to none. But the injection site reaction continues. Originally the symptoms started about 2.5hrs post injection.
later in day devel chills-extreme lt upper arm pain @ inj site;swollen & red day following pain was dec replaced w/burning;covering MD advised APAP, DPH & ice or moist heat;
Within 12 hours of vaccine administration experienced muscle aches and pains in calves and legs. Took OTC anti inflammatory/pain meds.
This spontaneous report as received from a Administrator and refers to a 2 years old patient of unknown gender. No medication history, concurrent condition and concomitant medications were reported. On 25-MAY-2016, the patient was vaccinated with improperly stored dose of VARIVAX lot # L048468 (strength, dosing details, anatomical location were unknown). All the VARIVAX vaccines with lot # L048468, were moved to the backup freezer on 15-APR-2016 and moved back at the end of AUG-2016. This is one of the several reports reported by the same reporter. Additional information has been requested.
Very sick, then hospitalized Died; This is a spontaneous report from a contactable Other Health Professional (patient). A 71-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 28Jan2021 06:00 at single dose for COVID-19 immunization. Medical history included Esrd controlled a-fib.  Concomitant medication in two weeks included diphenhydramine hydrochloride (BENADRYL) before vaccine and some dialysis Ned maybe. Facility type vaccine: Other. If other vaccine in four weeks: No. If covid prior vaccination: No. The patient previously received first dose of BNT162B2 on an unspecified date for COVID-19 immunization. The patient experienced very sick on 29Jan2021.  The patient was not recovered from the event very sick. Event reported as Very sick and my father died. AE resulted in: Emergency room/department or urgent care, Hospitalization. AE treatment: Famotidine and nausea meds then hospitalized Died. It was unknown if an autopsy was done.  Information on batch/lot number has been requested.; Sender's Comments: The limited information provided precludes a full clinical assessment of the case. Significant in the assessment would be the date when the first dose of the vaccine was given, the patient's complete medical history, and the full clinical course of the event (including specific symptoms/events associated with reported 'very sick'), which were unknown at the time of this report. This case will be reassessed once with additional information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: Very sick, then hospitalized Died
It was reported, that a 6 month old pt received a Tripedia vaccination on 8/2/99. Reportedly, on 8/4/99, the pt developed a large local reaction and a low-grade fever. From additional information received on 8/19/99, additional pt and doctor information was provided.
Hepatitis-A vaccine was ordered, but Hepatitis-B vaccine was given in error; patient received an extra dose of Hepatitis-B vaccine.
Patient is a 84 y.o. male who presented from home on 9/5/2023 with SOB, positive COVID with acute respiratory failure.  Was treated with Decadron with improvement.  Patient was weaned down to room air.  Was asymptomatic on the day of discharge.  Discharged to skilled nursing facility for physical deconditioning        Assessment and Plan   Acute respiratory failure with hypoxia COVID pneumonia - Presented with: SOB, cough - Symptom onset: 9/5/23 - Positive COVID-19: at PCP office - Vaccination status: Vaccinated and boosted  - CXR on admission showed mild cardiomegaly, minimal fluid/atelectasis in the left lung  - Oxygen status: started on 15L HFNC on admit, now on room air - Decadron: Yes. Expected end date 9/15/23.  Patient is currently on room air.  Per discussion with wife at the bedside discontinued Decadron - Remdesivir: Completed 5 day course -Discussed with nursing staff importance of pulmonary hygiene - DVT prophylaxis:Currently on full anticoagulation - Serial COVID labs ordered: Yes - Case Management/Social Services consulted: Yes   Chronic atrial fibrillation  - Has previous CV/ablation and pacemaker.  -Rate is stable -Continue with Eliquis     Parkinson's disease Dementia without agitation - Follows with neurology. -Lives at home with wife w HH and PT -Progressive deconditioning in setting of acute illness.  Patient and wife agreed to skilled nursing facility. -Continue with home Sinemet, Aricept, and Seroquel nightly   Major depression in remission -Continue with BuSpar BID
Ever since I got the 2nd covid vacine, there has been pain in the site of the shot.  Sometimes it is stronger than other times.
After receiving my first shot ofthe vaccine the spots started goingaway. After my second shot one spotwas completely gone and the other isalmost gone; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EN6203) via an unspecified route administration in left arm on 26Feb2021 (at the age of 64-year-old) at 11:15 hours, as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EN6208) via an unspecified route administration in left arm on 17Mar2021 (at the age of 64-year-old)  at 13:15 as a single dose for COVID-19 immunisation. Medical history included Non-Hodgkin's Lymphoma. Patient did not have any allergies to medications, food, or other products. Concomitant medication included Tamsulosin (MANUFACTURER UNKNOWN), Losartan (MANUFACTURER UNKNOWN) and Pravastatin (MANUFACTURER UNKNOWN). Patient did not receive any other vaccine within 4 weeks prior to the covid-19. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19.  Patient reported that he had two spots of basil Cell skin cancer on right side of his face (Cheek). The basil cell was raised and scaly. After receiving the first shot of the vaccine the spots started going away (date unspecified). After the second shot (on 03Mar201) one spot was completely gone and the other was almost gone. He went to the dermatologist and they said they see no areas of concern (unexpected therapeutic benefit). No therapeutic measure was taken for the events. The clinical outcome of the events unexpected therapeutic benefit was unknown at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Developed severe pain at injections site. Fever with Tmax 102 x 3 days.  Body aches, headache, fatigue.  Flu and COVID tests negative. Did not improve with supportive care including heat, rest, NSAIDs, tylenol.  Due to persistent symptoms and severity of pain, labs completed on 11/29/20 including CBC (normal), CPK (26) and CRP (3.7).  Muscle pain persisted.  On 11/30/20 patient given Dexamethasone 6mg IM x1.  Symptoms gradually improved over the course of 2 weeks.
CALLED PFIZER. THERE WERE NO SIDE EFFECTS NOTED BY PATIENT.
Baby developed emesis 24 hours after vaccines given (Pediarix, HiB PRP-T, PNU CN, Rota 5).  Emesis multiple times over following 48 hours, no diarrhea, no fever.  Poor appetite for 3 days.